Compiling Pre-DSHEA Ingredient List Relies On Bridging FDA-Industry Gap
This article was originally published in The Rose Sheet
Executive Summary
"Nobody said these are easy questions, if they were they would have been answered a long time ago," says Steve Tave, director of FDA's Office of Dietary Supplement Programs. Industry stakeholders at a public meeting recommend a reasonable threshold for evidence that verifies a dietary ingredient was available in the US before Congress passed DSHEA.
You may also be interested in...
NIH Office Of Dietary Supplements Keeps Tabs On What DSHEA Wrought For US Consumers
While working to improve the quality of VMS products available in the US and to provide information on the products to consumers, the ODS doesn’t have authority to impose change on the industry or in the marketplace.
AHPA Offers Hard Copy Supporting NAC's Use In Dietary Supplements Pre-DSHEA
American Herbal Products Association submits comments to on CRN and NPA petitions encouraging FDA to grant an industry request to issue a regulation finding NAC is a lawful dietary ingredient.
Naturopath, Regulatory Expert MacKay Returns To DC As CHPA’s Supplement Industry Strategy Chief
Consumer Healthcare Products Association names Duffy MacKay as its first senior VP for dietary supplements. Former CRN executive moves from CV Sciences back into trade group world.